{"entity":{"id":"nct06781567","kind":"trial","name":"Clinical Trial of HG146 Administered to Participants with Adenoid Cystic Carcinoma","aka":[],"tldr":"A phase 2 trial of HG146 in salivary gland cancers and head and neck squamous cell carcinoma, run by HitGen Inc., now recruiting.","summary":"Clinical Trial of HG146 Administered to Participants with Adenoid Cystic Carcinoma is a phase 2 interventional study registered as NCT06781567 by HitGen Inc., with 140 participants planned, started 2024-12-13 and due to reach its primary completion in 2028-12-31. Interventions recorded: HG146.","status":"recruiting","asOf":"2026-09-16","links":[{"label":"ClinicalTrials.gov NCT06781567","url":"https://clinicaltrials.gov/study/NCT06781567"}],"tags":["pipeline","ctgov-ingest"],"related":[],"cancers":["salivary-gland","head-and-neck"],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"notes":[],"nct":"NCT06781567","phase":"2","setting":"A Phase Il Clinical Study to Evaluate the Efficacy and Safety of HG146 Capsules in Participants with Recurrent or Metastatic Adenoid Cystic Carcinoma.","sponsor":"HitGen Inc.","enrolled":140,"outcomes":[]},"route":"/trials/nct06781567/","neighbours":{"cancer":[{"id":"head-and-neck","kind":"cancer","name":"Head and neck squamous cell carcinoma","route":"/cancers/head-and-neck/"},{"id":"salivary-gland","kind":"cancer","name":"Salivary gland cancers","route":"/cancers/salivary-gland/"}]}}